Janssen-Cilag International NV Release: New and Long-Term Use Results for Canagliflozin to be Presented at European Association for the Study of Diabetes Annual Meeting
Published: Sep 18, 2013
BEERSE, Belgium--(BUSINESS WIRE)--Janssen-Cilag International NV (Janssen) announced today that 12 presentations on canagliflozin will be made at the upcoming annual meeting of the European Association for the Study of Diabetes (EASD), from September 24-27 in Barcelona, Spain.
Help employers find you! Check out all the jobs and post your resume.